Vanda Pharmaceuticals (VNDA) Current Taxes (2010 - 2011)
Vanda Pharmaceuticals' (VNDA) quarterly Current Taxes came in at $2.1 million in Q3 2011, down 5.09% quarter-over-quarter from $2.2 million in Q2 2011.
Vanda Pharmaceuticals (VNDA) Current Taxes (2010 - 2011) Analysis & Trends
Vanda Pharmaceuticals has disclosed Current Taxes across 2 years of filings, most recently posting $2.1 million for Q3 2011.
- Current Taxes for Q3 2011 came in at $2.1 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2011 was $2.1 million (changed N/A YoY), and the FY2010 annual result was $2.3 million, changed N/A from the prior year.
- Current Taxes came in at $2.1 million for Q3 2011 at Vanda Pharmaceuticals, down from $2.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $2.3 million in Q4 2010 to a low of $2.1 million in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 345.46 Mn | 143.15 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 2.11 Mn |
| Jun 30, 2011 | 2.22 Mn |
| Dec 31, 2010 | 2.27 Mn |